Melio
16 known investors
Find your way into Melio
Melio develops a rapid bloodborne pathogen testing platform that identifies common pathogens from blood samples within hours, replacing traditional multi-day culture-based diagnostics.
Founders & leadership
MS
Mridu Sinha, PhDCo-Founder and CEO
SF
Stephanie Fraley, PhDCo-Founder
Investors · 16
Cove FundIrvine · $250K – $1M
Lexi VenturesSan Francisco
LongeVCWashington D.C.
AccelreportedPalo Alto · $1.6M – $70M
Bessemer Venture PartnersreportedRedwood City · $5M – $100M
Capital One VenturesreportedMcLean
Coatue ManagementreportedNew York · $1M – $20M
Frontline VenturesreportedSan Francisco · $540K – $3.2M
.png)
General Catalystreported · 2 sourcesSan Francisco · $30M
ShopifyreportedOttawa
Thrive CapitalreportedNew York · $500K – $25M
Also in the syndicate · 5
Capital OneFiservleadFiserv, Inc.leadLatitudeShopify Ventures
Funding
SEC filings, press & company announcements$150M disclosed across 1 of 5 rounds · 2020–2024
- Undisclosed amountSeries ENov 2024Source ↗
- $150MSeries EOct 2024 · 2 sources
Fiserv (lead), Fiserv, Inc. (lead), Accel, Bessemer, Capital One, Capital One Ventures, Coatue, Frontline Ventures, General Catalyst, Latitude, Shopify, Shopify Ventures, Thrive Capital
Source ↗ - Undisclosed amountSeries DSep 2021Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Melio do?
- Melio develops a rapid bloodborne pathogen testing platform that identifies common pathogens from blood samples within hours, replacing traditional multi-day culture-based diagnostics.
- Who founded Melio?
- Melio was founded by Mridu Sinha, PhD, Stephanie Fraley, PhD.
- Who are Melio's investors?
- Melio's investors include Cove Fund, Lexi Ventures, LongeVC, Accel, Bessemer Venture Partners, Capital One Ventures, Coatue Management, Frontline Ventures and 3 more.
- How much funding has Melio raised?
- Melio has disclosed $150M raised across 1 of its 5 known rounds.